Triple inhaled therapy in COPD: prevention of exacerbations versus the risk of pneumonia. Critical reflections from GOLD and clinical evidence

Triple inhaled therapy in COPD: prevention of exacerbations versus the risk of pneumonia. Critical reflections from GOLD and clinical evidence

Rafael de J. Hernández-Zenteno

Clínica de EPOC, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Ciudad de México, México

*Correspondence: Rafael de J. Hernández-Zenteno. Email: rafherzen@yahoo.com.mx

Contents

Content available only in Spanish.

DOI not available

Content available only in Spanish.

    DOI not available